ALDH1A1 and ovarian serous adenocarcinoma: We also observed increased ALDH1 positivity in serous ovarian cancer tissues obtained from patients that had received neoadjuvant chemotherapy or had relapsed compared to chemonaïve tissues from patients who had not received chemotherapy.